SLC10A1 and fibrosis: These findings support taurocholate’s involvement in liver pathology, possibly through enhanced sodium-taurocholate cotransporting polypeptide (NTCP)-mediated uptake, consistent with studies showing increased taurocholic acid trafficking and hepatic stellate cell activation in advanced fibrosis [14].